Immunotherapy of chronic active viral hepatitis B with propionibacterium granulosum.

Abstract

12 HBsAg-positive patients with chronic active hepatitis B were treated monthly with cell walls (5 or 10 mg) of Propionibacterium granulosum KP-45 (PG) intravenously administered for a period of 6-10 months. The clinical state was evaluated according to an arbitrary 6-grade scale based on serum biochemical tests, HBV markers and the morphology of liver… (More)

Topics

Cite this paper

@article{Gil1984ImmunotherapyOC, title={Immunotherapy of chronic active viral hepatitis B with propionibacterium granulosum.}, author={J. Gil and J Ziemka and Witold J. Brzosko and Michele Dabrowski and B K Dabrowska-Bernstein and Stanisław Szmigielski and H. L. Ko and Janusz Jeljaszewicz and Gernot Pulverer}, journal={Hepato-gastroenterology}, year={1984}, volume={31 3}, pages={109-18} }